Original-Research

OHB SE (von NuWays AG): BUY 10.11.2025, 09:00 Uhr von dpa-AFX Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
OHB 316,00 EUR +5,86 % Tradegate

^

Original-Research: OHB SE - from NuWays AG

10.11.2025 / 09:00 CET/CEST

Dissemination of a Research, transmitted by EQS News - a service of EQS

Group.

The issuer is solely responsible for the content of this research. The

result of this research does not constitute investment advice or an

invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of NuWays AG to OHB SE

Company Name: OHB SE

ISIN: DE0005936124

Reason for the research: Initiation

Recommendation: BUY

Target price: EUR 141

Target price on sight of: 12 months

Last rating change:

Analyst: Henry Wendisch

Space coverage relaunched; re-initiate OHB with BUY

With no further information on the intended delisting, it appears that OHB

has chosen to remain a listed company for the time being. Therefore, we

relaunch our active coverage with this in-depth report.

Since our last update in August 2024, dynamics improved materially at OHB

and in the space sector:

Germany's newly unveiled EUR 35bn space defence budget (FY'26-30) positions

OHB as a key national champion poised to benefit from the defence

super-cycle. Assuming a 20% budget share (eNuW), OHB should secure EUR 7bn in

orders, indicating a fundamental revenue shift (defence currently only

accounts for 10% of sales). Importantly, OHB's order intake and backlog have

already reached record levels thanks to prospering civil demand, e.g. from

the ESA flagship mission LISA awarded to OHB in Q2'25 (order size: EUR 839m).

In this oligopolistic market, OHB is Europe's #3 space OEM and only listed

space-tech pure play. A planned merger between the #1 and #2 prompted by

weakness, in our view (also see p. 7) changes the competitive landscape with

OHB being the likely beneficiary.

To further capitalize on their strong positioning, OHB acquired the

remaining 30% of MT Aerospace (c.12% of group output) and has expanded

vertically and geographically, taking over TechniSat's Saxony facility to

internalize satellite electronics production, and entering the UK as

Europe's fourth largest space market to capture geo-return opportunities.

At the same time, OHB generates solid FCFs (although fluctuating due to the

nature of the project business) and has ROCEs well above capital costs,

underscoring the value-accretive nature of its business model. In addition,

EBIT margins look set to expand to 10.5% by 2030e (+3.5pp vs adj. 2025e

level, eNuW), following a comprehensive efficiency programme, which already

shows a tangible impact (see p. 12) and thanks to operating leverage.

Consequently, EBIT is seen to grow at a 24% CAGR into 2030e (eNuW).

The story is not short of catalysts: the ESA Ministerial Council (Nov 2025)

is expected to set the European civil space budget at EUR 20-23bn (eNuW,

18-30% over 2022), with a fundamental paradigm shift towards dual-use

capabilities. Moreover, we expect the German-French JEWEL/Odin's Eye II

missile early-warning programme to be awarded to OHB as prime contractor

(eNuW: EUR 1-2bn volume), where the company has already completed the

feasibility and pre-development studies.

In sum, OHB is evolving from a predominantly civil space player into a

strategic asset for Europe's space defence. Supported by record backlog,

vertical and geographic expansion, and favourable market dynamics, the

company is entering a decade of above-average growth.

Against this backdrop, we re-initiate with BUY. Our PT of EUR 141 reflects a

40% upside and is based on DCF. Also a peer group analysis indicates a 30%

discount on 2027e EV/EBIT.

You can download the research here:

https://eqs-cockpit.com/c/fncls.ssp?u=1f789a90fcac4b2715391daa038f6eb9

For additional information visit our website:

https://www.nuways-ag.com/research-feed

Contact for questions:

NuWays AG - Equity Research

Web: www.nuways-ag.com

Email: research@nuways-ag.com

LinkedIn: https://www.linkedin.com/company/nuwaysag

Adresse: Mittelweg 16-17, 20148 Hamburg, Germany

++++++++++

Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss

bestimmter Börsengeschäfte.

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben

analysierten Unternehmen befinden sich in der vollständigen Analyse.

++++++++++

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

View original content:

https://eqs-news.com/?origin_id=5d754672-be08-11f0-be29-0694d9af22cf&lang=en

---------------------------------------------------------------------------

2226586 10.11.2025 CET/CEST

°

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer